|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"ren z"
Showing items 1-25 of 41 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-08-19T00:20:34Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Douillard J.-Y.; Yoshino T.; Yen Y.; Hsu C.-H.; Tabernero J.; Shen Y.-C.; CHIUN HSU; Chen S.-C.; Huang Y.-H.; Yen C.-J.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Pentheroudakis G.; Cheng A.-L.; Chen L.-T.; Martinelli E. |
| 臺大學術典藏 |
2022-06-10T06:10:59Z |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin S.; Chan S.L.; Sukeepaisarnjaroen W.; Han G.; Choo S.P.; Sriuranpong V.; Pan H.; Yau T.; Guo Y.; Chen M.; Ren Z.; Xu J.; Yen C.-J.; ZHONG-ZHE LIN; Manenti L.; Gu Y.; Sun Y.; Tiedt R.; Hao L.; Song W.; Tanwandee T. |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
|
Qin S.; Ren Z.; Feng Y.-H.; Yau T.; Wang B.; Zhao H.; Bai Y.; Gu S.; Li L.; Hernandez S.; Xu D.-Z.; Mulla S.; Wang Y.; Shao H.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT
|
Okusaka T.; Ikeda K.; Kudo M.; Finn R.; Qin S.; Han K.-H.; ANN-LII CHENG; Piscaglia F.; Kobayashi M.; Sung M.; Chen M.; Wyrwicz L.; Yoon J.-H.; Ren Z.; Mody K.; Dutcus C.; Tamai T.; Ren M.; Hayato S.; Kumada H. |
| 國立成功大學 |
2022 |
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
|
Zhu, A.X.;Dayyani, F.;Yen, C.-J.;Ren, Z.;Bai, Y.;Meng, Z.;Pan, H.;Dillon, P.;Mhatre, S.K.;Gaillard, V.E.;Hernandez, S.;Kelley, R.K.;Sangro, B. |
| 臺大學術典藏 |
2021-08-31T06:29:18Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen L.-T.; Martinelli E.; ANN-LII CHENG; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Hsu C.; Shen Y.-C.; Tabernero J.; Yen Y.; Hsu C.-H.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-08-31T06:29:13Z |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo B.-Y.; ANN-LII CHENG; Ren Z.; Kim T.-Y.; Pan H.; Rau K.-M.; Choi H.J.; Park J.-W.; Kim J.H.; Yen C.J.; Lim H.Y.; Zhou D.; Straub J.; Scheele J.; Berghoff K.; Qin S. |
| 臺大學術典藏 |
2021-08-11T03:46:38Z |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin S.; Chan S.L.; Sukeepaisarnjaroen W.; Han G.; Choo S.P.; Sriuranpong V.; Pan H.; Yau T.; Guo Y.; Chen M.; Ren Z.; Xu J.; Yen C.-J.; ZHONG-ZHE LIN; Manenti L.; Gu Y.; Sun Y.; Tiedt R.; Hao L.; Song W.; Tanwandee T. |
| 臺大學術典藏 |
2021-03-09T05:18:30Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen L.-T.; Martinelli E.; Cheng A.-L.; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Hsu C.; Ying-Chun Shen; Tabernero J.; Yen Y.; Hsu C.-H.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-02-18T02:33:47Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen L.-T.;Martinelli E.;Cheng A.-L.;Pentheroudakis G.;Qin S.;Bhattacharyya G.S.;Ikeda M.;Lim H.-Y.;Ho G.F.;Choo S.P.;Ren Z.;Malhotra H.;Ueno M.;Ryoo B.-Y.;Kiang T.C.;Tai D.;Vogel A.;Cervantes A.;Lu S.-N.;Yen C.-J.;Huang Y.-H.;Chen S.-C.;Shen Y.-C.;Tabernero J.;Yen Y.;Chiun Hsu;Yoshino T.;Douillard J.-Y.; Chen L.-T.; Martinelli E.; Cheng A.-L.; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Shen Y.-C.; Tabernero J.; Yen Y.; Chiun Hsu; Yoshino T.; Douillard J.-Y. |
| 國立成功大學 |
2021 |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo, B.-Y.;Cheng, A.-L.;Ren, Z.;Kim, T.-Y.;Pan, H.;Rau, K.-M.;Choi, H.J.;Park, J.-W.;Kim, J.H.;Yen, C.J.;Lim, H.Y.;Zhou, D.;Straub, J.;Scheele, J.;Berghoff, K.;Qin, S. |
| 臺大學術典藏 |
2020-05-15T07:00:58Z |
Topographic Loads Modified by Fluvial Incision Impact Fault Activity in the Longmenshan Thrust Belt, Eastern Margin of the Tibetan Plateau
|
Tan, X.;Yue, H.;Liu, Y.;Xu, X.;Shi, F.;Xu, C.;Ren, Z.;Shyu, J.B.H.;Lu, R.;Hao, H.; Tan, X.; Yue, H.; Liu, Y.; Xu, X.; Shi, F.; Xu, C.; Ren, Z.; Shyu, J.B.H.; Lu, R.; Hao, H.; J. BRUCE H. SHYU |
| 臺大學術典藏 |
2020-04-28T07:12:58Z |
Digitally-specified micromechanical displacement amplifiers
|
WEI-CHANG LI; Nguyen, C.T.-C.; Kim, B.; Ren, Z.; Lin, Y.-W.; Li, S.-S.; Gurin, I.; Li, W.-C.; Lin, Y. |
| 臺大學術典藏 |
2020-04-28T07:12:58Z |
Enhancement of micromechanical resonator manufacturing precision via mechanically-coupled arraying
|
Lin, Y.; Li, W.-C.; Kim, B.; Lin, Y.-W.; Ren, Z.; Nguyen, C.T.-C.; WEI-CHANG LI |
| 臺大學術典藏 |
2020-04-28T07:12:58Z |
Micromechanical resonant displacement gain stages
|
Kim, B.; Lin, Y.; Huang, W.-L.; Akgul, M.; Li, W.-C.; Ren, Z.; Nguyen, C.T.-C.; WEI-CHANG LI |
| 臺大學術典藏 |
2020-04-28T07:12:57Z |
Hollow stems for higher micromechanical disk resonator quality factor
|
Akgul, M.; Ren, Z.; Lin, Y.; Li, W.-C.; Nguyen, C.T.-C.; WEI-CHANG LI; Wu, L. |
| 臺大學術典藏 |
2020-04-28T07:12:57Z |
Acceleration sensitivity of small-gap capacitive micromechanical resonator oscillators
|
Kim, B.; Akgul, M.; Lin, Y.; Li, W.-C.; Ren, Z.; Nguyen, C.T.-C.; WEI-CHANG LI |
| 臺大學術典藏 |
2020-04-28T07:12:57Z |
Quality factor enhancement in micromechanical resonators at cryogenic temperatures
|
Li, W.-C.; Lin, Y.; Kim, B.; Ren, Z.; Nguyen, C.T.-C.; WEI-CHANG LI |
| 臺大學術典藏 |
2020-04-28T07:12:57Z |
Micromechanical disk array for enhanced frequency stability against bias voltage fluctuations
|
Wu, L.; Akgul, M.; Li, W.-C.; Lin, Y.; Ren, Z.; Rocheleau, T.; Nguyen, C.T.-C.; WEI-CHANG LI |
| 臺大學術典藏 |
2020-04-21T03:52:02Z |
Atomic-scale strain manipulation of a charge density wave
|
Flicker, F.; Sankar, R.; Zhao, H.; Ren, Z.; Rachmilowitz, B.; Balachandar, S.; Chou, F.; Burch, K. S.; Wang, Z.; van Wezel, J.; Zeljkovic, I.; Gao, S. |
| 臺大學術典藏 |
2020-03-23T07:19:17Z |
Common genetic determinants of breast-cancer risk in east asian women: A collaborative study of 23 637 breast cancer cases and 25 579 controls
|
Zhang B.; Zheng W.; Zheng W.;Zhang B.;Cai Q.;Sung H.;Michailidou K.;Shi J.;Choi J.-Y.;Long J.;Dennis J.;Humphreys M.K.;Wang Q.;Lu W.;Gao Y.-T.;Li C.;Cai H.;Park S.K.;Yoo K.-Y.;Noh D.-Y.;Han W.;Dunning A.M.;Benitez J.;Vincent D.;Bacot F.;Tessier D.;Kim S.-W.;Lee M.H, Lee J.W, Lee J.-Y.;Xiang Y.-B.;Zheng Y.;Wang W.;Ji B.-T.;Matsuo K.;Ito H.;Iwata H.;Tanaka H.;Wu A.H.;Tseng C.-C.;Van Den Berg D.;Stram D.O.;Teo S.H, Yip C.H, Kang I.N, Wong T.Y.;Shen C.-Y.;Yu J.-C.;Chiun-Sheng Huang;Hou M.-F.;Hartman M.;Miao H.;Lee S.C, Putti T.C, Muir K.;Lophatananon A.;Stewart-Brown S.;Siriwanarangsan P.;Sangrajrang S.;Shen H.;Chen K.;Wu P.-E.;Ren Z.;Haiman C.A.;Sueta A.;Kim M.K, Khoo U.S, Iwasaki M.;Pharoah P.D.P.;Wen W.;Hall P.;Shu X.-O.;Easton D.F.;Kang D.; Stewart-Brown S.; Lophatananon A.; Miao H.; Lee S.C, Putti T.C, Muir K.; Hou M.-F.; Hartman M.; Yu J.-C.; CHIUN-SHENG HUANG; Shen C.-Y.; Teo S.H, Yip C.H, Kang I.N, Wong T.Y.; Stram D.O.; Van Den Berg D.; Tseng C.-C.; Wu A.H.; Tanaka H.; Iwata H.; Cai Q.; Sung H.; Michailidou K.; Shi J.; Choi J.-Y.; Long J.; Dennis J.; Humphreys M.K.; Wang Q.; Lu W.; Gao Y.-T.; Li C.; Cai H.; Park S.K.; Yoo K.-Y.; Noh D.-Y.; Han W.; Dunning A.M.; Benitez J.; Vincent D.; Bacot F.; Tessier D.; Kim S.-W.; Lee M.H, Lee J.W, Lee J.-Y.; Xiang Y.-B.; Zheng Y.; Wang W.; Ji B.-T.; Matsuo K.; Ito H.; Siriwanarangsan P.; Sangrajrang S.; Shen H.; Chen K.; Wu P.-E.; Ren Z.; Haiman C.A.; Sueta A.; Kim M.K, Khoo U.S, Iwasaki M.; Pharoah P.D.P.; Wen W.; Hall P.; Shu X.-O.; Easton D.F.; Kang D. |
| 國家衛生研究院 |
2020-03 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, LT;Martinelli, E;Cheng, AL;Pentheroudakis, G;Qin, S;Bhattacharyya, GS;Ikeda, M;Lim, HY;Ho, GF;Choo, SP;Ren, Z;Malhotra, H;Ueno, M;Ryoo, BY;Kiang, TC;Tai, D;Vogel, A;Cervantes, A;Lu, SN;Yen, CJ;Huang, YH;Chen, SC;Hsu, C;Shen, YC;Tabernero, J;Yen, Y;Hsu, CH;Yoshino, T;Douillard, JY |
| 臺大學術典藏 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Douillard J.-Y.; Yoshino T.; CHIH-HUNG HSU; Yen Y.; Tabernero J.; Shen Y.-C.; Hsu C.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Cheng A.-L.; Martinelli E.; Chen L.-T.; Chen L.-T.;Martinelli E.;Cheng A.-L.;Pentheroudakis G.;Qin S.;Bhattacharyya G.S.;Ikeda M.;Lim H.-Y.;Ho G.F.;Choo S.P.;Ren Z.;Malhotra H.;Ueno M.;Ryoo B.-Y.;Kiang T.C.;Tai D.;Vogel A.;Cervantes A.;Lu S.-N.;Yen C.-J.;Huang Y.-H.;Chen S.-C.;Hsu C.;Shen Y.-C.;Tabernero J.;Yen Y.;Chih-Hung Hsu;Yoshino T.;Douillard J.-Y.; Choo S.P.; Ho G.F.; Lim H.-Y.; Ikeda M.; Bhattacharyya G.S.; Qin S.; Pentheroudakis G. |
| 國立成功大學 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, L.-T.;Martinelli, E.;Cheng, A.-L.;Pentheroudakis, G.;Qin, S.;Bhattacharyya, G.S.;Ikeda, M.;Lim, H.-Y.;Ho, G.F.;Choo, S.P.;Ren, Z.;Malhotra, H.;Ueno, M.;Ryoo, B.-Y.;Kiang, T.C.;Tai, D.;Vogel, A.;Cervantes, A.;Lu, S.-N.;Yen, C.-J.;Huang, Y.-H.;Chen, S.-C.;Hsu, C.;Shen, Y.-C.;Tabernero, J.;Yen, Yen Y.;Hsu, C.-H.;Yoshino, T.;Douillard, J.-Y. |
| 國立成功大學 |
2020 |
Mapping essential urban land use categories in China (EULUC-China): preliminary results for 2018
|
Gong, P.;Chen, B.;Li, X.;Liu, H.;Wang, J.;Bai, Y.;Chen, J.;Chen, X.;Fang, L.;Feng, S.;Feng, Y.;Gong, Y.;Gu, H.;Huang, Huang H.;Huang, X.;Jiao, H.;Kang, Y.;Lei, G.;Li, A.;Li, X.;Li, X.;Li, Y.;Li, Z.;Li, Z.;Liu, C.;Liu, C.;Liu, M.;Liu, S.;Mao, W.;Miao, C.;Ni, H.;Pan, Q.;Qi, S.;Ren, Z.;Shan, Z.;Shen, Shen S.;Shi, M.;Song, Y.;Su, M.;Ping, Suen H.;Sun, B.;Sun, F.;Sun, J.;Sun, L.;Sun, W.;Tian, Tian T.;Tong, X.;Tseng, Y.;Tu, Y.;Wang, H.;Wang, L.;Wang, X.;Wang, Z.;Wu, T.;Xie, Y.;Yang, J.;Yang, J.;Yuan, M.;Yue, W.;Zeng, H.;Zhang, K.;Zhang, N.;Zhang, T.;Zhang, Y.;Zhao, F.;Zheng, Y.;Zhou, Q.;Clinton, N.;Zhu, Zhu Z.;Xu, B. |
Showing items 1-25 of 41 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
